Target intelligence / Profile preview

Novel Triggering Receptor Expressed on Myeloid Cells (TREM) Family Member (Novel TREM Receptor)

Target
Novel TREM Receptor
Molecular classification
Receptor, Immunoglobulin superfamily member
01

Overview

A newly identified or characterized cell surface receptor belonging to the TREM family, expressed on antigen-presenting cells (APCs) such as dendritic cells and macrophages, as well as some lymphoid cells. It acts as an activating receptor, enhancing antigen presentation capabilities and modulating downstream immune responses upon ligand binding. Downstream signaling involves adapter proteins like DAP12, leading to phosphorylation cascades and gene transcription relevant for inflammation or tolerance. Understanding its specific ligands and signaling pathways could have implications for vaccine development and modulating autoimmune responses.

Other names
Novel Activating Receptor on APCsNovel TREM-family ReceptorTREM Receptor on Dendritic Cells
02

Mechanism of action

Ligand binding induces activation signals via adapter proteins (e.g., DAP12) leading to phosphorylation cascades and gene transcription relevant for inflammation or tolerance.

03

Biological functions

Immune responseAntigen presentationCell activationSignal transduction
04

Disease associations

AutoimmunityInfectionInflammation
05

Safety considerations

Potential for off-target effects due to expression on multiple cell typesRisk of exacerbating inflammatory responses or inducing autoimmunity

Beyond the preview

Go deeper on Novel Triggering Receptor Expressed on Myeloid Cells (TREM) Family Member (Novel TREM Receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Triggering Receptor Expressed on Myeloid Cells (TREM) Family Member (Novel TREM Receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call